Clinical Trials Research
Reports from California Pacific Medical Center Advance Knowledge in Clinical Trials Research
Published in Clinical Trials Week, February 21st, 2011
2011 FEB 21 -- Researchers detail in 'A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction,' new data in Clinical Trials Research. "Sixty treatment-seeking individuals with methamphetamine (MA) dependence entered a randomized, placebo-controlled, double-blind clinical trial of oral dextroamphetamine (d-AMP) as a replacement therapy for MA dependence. The subjects took 60 mg sustained-release d-AMP for 8 weeks, during which time they received eight 50-min sessions of individual psychotherapy," scientists in the United States report.
"Adverse events and urine toxicology for MA were assessed...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2011-02-21)
More Articles from Clinical Trials Week
- Leukemia
ARIAD to Present at the 13th Annual BIO CEO & Investor Conference - Aetna
Aetna Recognized by National Comprehensive Cancer Network for Evidence-Based Approach to Cancer Care - Biotechnology
Almac Opens Analytical Labs in New US Headquarters - Clinical Trials Research
Cephalon Signs Option Agreement to Acquire Assets from Alba Therapeutics - Pediatrics
Childhood cancer research in danger - Clinical Trials Research
Concentric Medical Announces First Patients Enrolled In TREVO 2 Clinical Trial - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
